Disease course heterogeneity and OCT in multiple sclerosis

Multiple Sclerosis Journal

Volumn 20, Issue 9, 2014, Pages 1198-1206

  Balk, L J ^a   Tewarie, P ^a   Killestein, J ^a   Polman, C H ^a   Uitdehaag, Bmj ^a   Petzold, A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

disease course; Multiple sclerosis; neurodegeneration; optical coherence tomography; retinal layer segmentation

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY DEVICE; RETINA DISEASE; RETINAL LAYER ATROPHY; RETINAL NERVE FIBER LAYER THICKNESS; SENSITIVITY AND SPECIFICITY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VERY ELDERLY; AREA UNDER THE CURVE; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PREDICTIVE VALUE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETINA; YOUNG ADULT; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EYE DISEASE; IMAGE ANALYSIS; NERVE CELL DEGENERATION; OUTCOME ASSESSMENT;

ADULT; AREA UNDER CURVE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETINA; ROC CURVE; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 84904193571     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513518626     Document Type: Article

References (35)

1. Compston A, Coles A. Multiple sclerosis. Lancet. 2008 ; 372: 1502-1517
2. Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: A position paper. Ann Neurol. 2000 ; 47: 831-835 (Pubitemid 30390209)
3. Thompson A. Overview of primary progressive multiple sclerosis (PPMS): Similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis. Mult Scler. 2004 ; 10: S2 - S7
4. Correale J, Ysrraelit MC, Fiol MP. Benign multiple sclerosis: Does it exist?. Curr Neurol Neurosci Rep. 2012 ; 12: 601-609
5. Ramsaransing GS, De Keyser J. Benign course in multiple sclerosis: A review. Acta Neurol Scand. 2006 ; 113: 359-369 (Pubitemid 44046321)
6. Rovaris M, Barkhof F, Calabrese M, et al. MRI features of benign multiple sclerosis: Toward a new definition of this disease phenotype. Neurology. 2009 ; 72: 1693-1701
7. Patrikios P, Stadelmann C, Kutzelnigg A, et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain. 2006 ; 129: 3165-3172 (Pubitemid 44871433)
8. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998 ; 338: 278-285 (Pubitemid 28065253)
9. Geurts JJ, Calabrese M, Fisher E, et al. Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol. 2012 ; 11: 1082-1092
10. Evangelou N, DeLuca GC, Owens T, et al. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain. 2005 ; 128: 29-34 (Pubitemid 40070517)
11. Miller DH. Biomarkers and surrogate outcomes in neurodegenerative disease: Lessons from multiple sclerosis. NeuroRx. 2004 ; 1: 284-294 (Pubitemid 46591886)
12. Fisher E, Lee JC, Nakamura K, et al. Gray matter atrophy in multiple sclerosis: A longitudinal study. Ann Neurol. 2008 ; 64: 255-265
13. Rovaris M, Rocca MA, Filippi M. Magnetic resonance-based techniques for the study and management of multiple sclerosis. Br Med Bull. 2003 ; 65: 133-144 (Pubitemid 36406462)
14. Kalkers NF, Ameziane N, Bot JC, et al. Longitudinal brain volume measurement in multiple sclerosis: Rate of brain atrophy is independent of the disease subtype. Arch Neurol. 2002 ; 59: 1572-1576
15. De Stefano N, Giorgio A, Battaglini M, et al. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology. 2010 ; 74: 1868-1876
16. Khoury S, Bakshi R. Cerebral pseudoatrophy or real atrophy after therapy in multiple sclerosis. Ann Neurol. 2010 ; 68: 778-779
17. Barkhof F, Calabresi PA, Miller DH, et al. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol. 2009 ; 5: 256-266
18. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991 ; 254: 1178-1181 (Pubitemid 21917444)
19. Balk LJ, Twisk JWR, Steenwijk MD, et al. A dam for axonal degeneration in multiple sclerosis. Mult Scler. 2013 ; 19: 74-558
20. Siepman TAM, Bettink-Remeijer MW, Hintzen RQ. Retinal nerve fiber layer thickness in subgroups of multiple sclerosis, measured by optical coherence tomography and scanning laser polarimetry. J Neurol. 2010 ; 257: 1654-1660
21. Henderson APD, Trip SA, Schlottmann PG, et al. An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain. 2008 ; 131: 277-287
22. Gelfand JM, Goodin DS, Boscardin WJ, et al. Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS One. 2012 ; 7: e36847
23. Oberwahrenbrock T, Schippling S, Ringelstein M, et al. Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography. Mult Scler Int. 2012 ; 2012: 530305
24. Pulicken M, Gordon-Lipkin E, Balcer LJ, et al. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology. 2007 ; 69: 2085-2092 (Pubitemid 350175711)
25. Costello F, Hodge W, Pan YI, et al. Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes. J Neurol Sci. 2009 ; 281: 74-79
26. Ratchford JN, Saidha S, Sotirchos ES, et al. Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology. 2013 ; 80: 47-54
27. Saidha S, Syc SB, Durbin MK, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler. 2011 ; 17: 1449-1463
28. Albrecht P, Ringelstein M, Müller AK, et al. Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography. Mult Scler. 2012 ; 18: 1422-1429
29. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 ; 46: 907-911
30. Tewarie P, Balk L, Costello F, et al. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS One. 2012 ; 7: e34823
31. Oberwahrenbrock T, Traber G, Gabilondo I, et al. Multicenter inter-rater reliability of retinal layer segmentation using spectral-domain OCT.. :
32. Petzold A, de Boer JF, Schippling S, et al. Optical coherence tomography in multiple sclerosis: A systematic review and meta-analysis. Lancet Neurol. 2010 ; 9: 921-932
33. Thompson AJ, Kermode AG, MacManus DG, et al. Patterns of disease activity in multiple sclerosis: Clinical and magnetic resonance imaging study. BMJ. 1990 ; 300: 631-634 (Pubitemid 20107324)
34. Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol. 1991 ; 29: 53-62
35. Miller DH, Leary SM. Primary-progressive multiple sclerosis. Lancet Neurol. 2007 ; 6: 903-912 (Pubitemid 47405002)